Budgetary Healthcare Institution of Omsk Region, Clinical Oncology Dispensary

Omsk 644013

0 studies enrolling now · 2 studies all time

What they study most

Non-Small Cell Lung Cancer, Small Cell Lung Cancer

Studies at this site

• Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer — Completed
• A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC — Completed